Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Stark Novus Financial Inc.Nu Ride Inc. Reports Improved Financials Following Bankruptcy Emergence, Net Income Turnaround
QXO, Inc.QXO, Inc. Reports Significant Financial Developments Following Strategic Changes and Investments
Global Gas CorpGlobal Gas Corporation Reports Mixed Financial Results, Net Income Recovery in Latest 10-Q Filing
Wilhelmina International, Inc.Wilhelmina International Reports Mixed Q3 Results, Net Income Up 28.6% for Nine Months
INTRUSION INCIntrusion Inc. Reports Mixed Revenue Performance, Improved Net Losses in Q3 2024
Verde Clean Fuels, Inc.Verde Clean Fuels Reports Operating Losses, Strategic Developments in Clean Fuels Technology Initiatives
Instil Bio, Inc.Instil Bio Reports Improved Financials, Reduced Operating Expenses, and Strategic Developments in Latest 10-Q Filing
Lexeo Therapeutics, Inc.Lexo Therapeutics Reports Financial Results, Advances Clinical Programs Amid Ongoing Losses
Marathon Bancorp, Inc. /MD/Marathon Bancorp Reports 102.9% Increase in Net Income, Net Income of $174,907 in Q3 2024
Advanced Flower Capital Inc.Advanced Flower Capital Inc. Reports Decline in Revenue and Profitability in Latest Quarter
Grace Therapeutics, Inc.Grace Therapeutics Reports Financial Results, Focuses on Lead Drug Candidate GTx-104
Clene Inc.Clene Inc. Reports Mixed Financial Results for Q3 and Nine Months Ended September 30, 2024
Liquidia CorpLiquidia Corporation Reports 21% Q3 Revenue Growth, Significant Expenses Increase, and Strategic Developments
Aerkomm Inc.Aerkomm Inc. Reports Significant Revenue Decline, Net Loss in Latest Quarter
Passage BIO, Inc.Passage Bio Reports Improved Financials, Net Loss Reduction, and Strategic Developments in Q3 2024
GridAI Technologies Corp.Entero Therapeutics Reports Improved Financials, Shifts Focus After ImmunogenX Acquisition
Venus Concept Inc.Venus Concept Reports Decline in Financial Performance for Q3 and Nine Months of 2024
Fulcrum Therapeutics, Inc.Fulcrum Therapeutics Reports Turnaround in Financial Performance, Net Income of $6.8M for Nine Months Ended September 30, 2024
Wag! Group Co.Wag! Group Reports Significant Revenue Decline and Net Loss in Latest Quarter
LEXICON PHARMACEUTICALS, INC.Lexicon Pharmaceuticals Reports Significant Revenue Growth, Net Loss in Q3 2024
Mural Oncology plcMural Oncology Reports Financial Results, Anticipates Continued Losses Amid Clinical Development Efforts
Unicycive Therapeutics, Inc.Unicycive Therapeutics Reports Improved Liquidity, Reduced Losses, and Advances in Key Drug Candidate
Acrivon Therapeutics, Inc.Acrivon Therapeutics Reports Strong Asset Growth, Net Loss in Latest Quarter
ARS Pharmaceuticals, Inc.ARS Pharmaceuticals Reports Revenue Growth, Net Loss in Q3 2024 Amid Product Launch and Expansion Efforts
Mastech Digital, Inc.Mastech Digital Reports Significant Financial Improvements in Q3 2024, Net Income Reaches $1.875 Million